Abstract:Aims/Purpose: To highlight the relevance of a therapeutic approach adapted to the clinical characteristics of the eyelid lesion found at the time of surgery to ensure an optimal functional and aesthetic result. Methods: Clinical case assessed, intervened and followed up at our centre. Results: A 76‐year‐old woman consulted for a nodular umbilicated lesion of recent appearance on the outer third of the upper eyelid of the left eye (UELE) measuring 0.5 cm in greatest diameter and 0.5 cm in elevation. The patient was placed on the waiting list for surgical excision and subsequent pathological examination (PE) of the lesion to confirm the initial clinical suspicion of keratoacanthoma (KA). One month later, the patient went to the operating room for surgery. During this time the lesion increased its initial size by more than 4 times, had a large necrotic centre, active borders and generated an evident left mechanical ptosis. As an alternative to the complete excisional surgery initially proposed, we offered the injection of neoadjuvant intralesional chemotherapy (CT) with the aim of reducing the size of the lesion to obtain a better functional and aesthetic result. The patient accepted this therapeutic alternative. KA was treated with weekly intralesional injections of 1 mL of methotrexate (MTX) 12.5 mg/mL. In our case, 3 injections were necessary to achieve a 78% reduction in the diameter of the lesion to allow reconstruction of the UELE with grafting of the contralateral upper eyelid. One week after the third injection of MTX, reconstruction of the UELE was performed after excisional surgery with wide margins for PE. One week later, the PE result ruled out malignancy and the graft had a pink appearance with complete vascular permeability, so the sutures were removed. Two weeks after reconstruction, the functional and aesthetic results were satisfactory. Conclusions: Therefore, in our experience, we recommend the above combined treatment for giant palpebral KA and stress the relevance of a therapeutic approach adapted to the clinical characteristics of the palpebral lesion at the time of surgery to ensure an optimal functional and aesthetic outcome. References 1. Patel NP, Cervino AL. Treatment of keratoacanthoma: is intralesional methotrexate an option? Can J Plast Surg 2011; 19: e15‐8.

Successful Treatment of a Giant Keratoacanthoma-Like Squamous Cell Carcinoma in the Eyebrow Using Surgery Combined with Photodynamic Therapy: A Case Report.

Keratoacanthoma‐like Squamous Cell Carcinoma Successfully Treated by the Surgery Combined with ALA‐PDT

Surgical management of facial malignant tumors

Recurrent squamous cell carcinoma of the upper eyelid treated with combination therapy of ALA photodynamic therapy and surgery with secondary healing

Novel Strategy in Giant Cutaneous Squamous Cell Carcinoma Treatment: the Case Experience with a Combination of Photodynamic Therapy and Surgery

Photodynamic therapy combined with carbon dioxide laser for successful treatment of cutaneous squamous cell carcinoma within a long-standing and huge seborrheic keratosis

Treatment of Nasal Squamous Cell Carcinoma with Combination of Surgery and Photodynamic Therapy

Successful treatment of hidradenocarcinoma using ALA-PDT combined with local narrow margin excision

A Combination of Laser-Assisted ALA-PDT for Squamous Cell Carcinoma in Situ and Field-Directed ALA-PDT for Actinic Keratosis.

Surgery sequential with 5-Aminolevulinic acid photodynamic therapy for lip squamous cell carcinoma: Two cases reports

Radiotherapy for Keratoacanthoma of Facial Skin: A Case Report and Review of Literature

Combined treatment of a giant palpebral keratoacanthoma

ALA-PDT successfully treated multiple cSCC in situ and AK in a patient with Epidermodysplasia verruciformis

Successful Treatment Of Upper-Left Eyelid Squamous Cell Carcinoma In An Epidermodysplasia Verruciformis Patient By Ala-Pdt/Holmium Laser Combination Therapy

Photodynamic therapy as an alternative treatment in patients with invasive cutaneous SCC where surgery is not feasible: Single center experience

Treatment of Primary Carcinomas of Facial Skin by Photodynamic Therapy with Topical Δ-Aminolaevulinic Acid

Photodynamic therapy combined with CO 2 laser for the treatment of seborrheic keratosis in the auricle: A case report

Combination Curettage and Modified ALA-PDT for Multiple Basal Cell Carcinomas of the Face and Head

Photodynamic Therapy of Intravenous Injection Combined with Intratumoral Administration of Photosensitizer in Squamous Cell Carcinoma.

Evaluating the safety and efficacy of aminolevulinic acid 20% topical solution activated by pulsed dye laser and blue light in the treatment of facial cutaneous squamous cell carcinoma in situ

Giant Nodule and Keratinized Facial Basal Cell Carcinoma:A Case Report